News & Perspective

Oct 14, 2004

Oct 14, 2004

Monkeys serve as first animal model of smallpox

(CIDRAP News) – Federal researchers report they have succeeded in infecting monkeys with fatal smallpox, creating the first animal model of the disease for use in testing vaccines and treatments for humans.

Jul 21, 2004

Jul 21, 2004

Bush signs BioShield legislation

(CIDRAP News) – President Bush today signed the bill establishing Project BioShield, a $5.6 billion program to speed the development of drugs and vaccines to combat the effects of biological, chemical, nuclear, and radiological agents.

May 20, 2004

May 20, 2004

Senate passes 'Bioshield' bill

(CIDRAP News) – The US Senate yesterday overwhelmingly passed "Project BioShield," a 10-year, $5.6 billion program to promote rapid development and use of drugs and vaccines to counter biological and chemical weapons.

Apr 28, 2004

Apr 28, 2004

Bush administration catalogs biodefense gains, promises more

(CIDRAP News) – The Bush administration today released a long catalog of what it considers the nation's biodefense and public health preparedness gains over the last 3 years and promised more improvements to come.

Apr 13, 2004

Apr 13, 2004

Myopericarditis cases complicate Acambis smallpox vaccine trials

(CIDRAP News) –British biotechnology company Acambis plc has temporarily stopped recruiting volunteers for clinical trials of the cell-culture smallpox vaccine it is making for the US government because at least three cases of myopericarditis have occurred in one of the trials.

Mar 12, 2004

Mar 12, 2004

FDA offers guidance on testing drugs for smallpox-shot side effects

(CIDRAP News) – The Food and Drug Administration (FDA) this week published guidelines for the development of drugs to treat the side effects of smallpox vaccination, an area in which the federal government is investing substantial research funds.

Sort Results By:

 Sort Results By:

Narrow results by:

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»